May 20, 2026. 10 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
Treatment delays rising among teens with cannabis use disorder – News-Medical.Net
Article Summary The article discusses cannabis use disorder treatment delays in adolescents and older adult preferences for edible cannabis products, which may interest clinicians tracking demographic patterns in cannabis consumption and clinical care access.
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →Cannabis News Today — 20 May 2026: Virginia Sales Veto
Article Summary Virginia governor’s veto of cannabis sales legislation; includes reference to McGill University cannabis research center collaborations, potentially relevant to clinicians monitoring regulatory and research developments.
Read more →Handheld Marijuana Medical Vaporizer Market to Reach US$ 20.3 – openPR.com
This article reports market projections for handheld medical vaporizer devices, noting emerging cannabis research activity in Europe, Australia, and Thailand—relevant for clinicians tracking delivery device commercialization and research expansion globally.
Read more →Virginia Gov. Spanberger vetoes retail cannabis legislation | NBC4 Washington – YouTube
Virginia’s governor vetoed retail cannabis legislation, representing a setback in the state’s legalization efforts and relevant to clinicians monitoring regulatory developments affecting patient access.
Read more →Study reveals cellular mechanisms driving resistance to targeted cancer therapies
This article examines genetic mechanisms connecting cannabis use to psychosis risk, relevant to clinicians assessing psychiatric adverse effects and patient vulnerability factors.
Read more →Marijuana and Employment Laws: Job Rights Explained
This article addresses workplace drug policies and employment rights related to marijuana use, relevant to clinicians advising patients on legal employment consequences of cannabis use.
Read more →Researchers Develop High-Temperature Stable Hemp-Derived Plastic from CBD
Article Summary Researchers developed a heat-resistant plastic material from hemp-derived CBD, potentially expanding industrial applications of cannabis plant compounds beyond traditional therapeutic uses.
Read more →Sunland Park cannabis dispensary permits rejected after council ratification fails – KFOX
Summary Sunland Park City Council rejected cannabis dispensary permits, illustrating how local regulatory decisions affect cannabis access and market development in specific jurisdictions.
Read more →Kentucky man arrested after police allegedly find 106 marijuana plants inside his home
Summary A Kentucky resident was arrested with 106 marijuana plants and firearms, illustrating law enforcement activity regarding large-scale home cultivation operations.
Read more →If marijuana came from the same community as Miraa, it wouldn’t be illegal. Miraa is …
Summary This social media post suggests cannabis legalization disparities may relate to the geographic origin of substances, comparing cannabis to miraa (khat), a legal plant stimulant in some regions.
Read more →Digest-Level Clinical Commentary
These items collectively highlight a fragmented landscape where cannabis medicine practice operates amid regulatory uncertainty, employment barriers, and emerging clinical evidence that demands our attention as physicians—particularly the growing recognition of cannabis use disorder in adolescents and potential psychiatric risks that warrant careful patient screening and informed consent. The persistent gap between legalization and actual access, combined with ongoing research into both therapeutic mechanisms and adverse effects, underscores that our role as clinicians must remain grounded in evidence-based assessment rather than either prohibition or assumption of safety. We need to help patients navigate the legal and employment complexities surrounding use while maintaining rigorous diagnostic criteria for when cannabis might be therapeutically justified versus when it represents a developing disorder.
These items reflect several concurrent trends in cannabis: increased recognition of cannabis use disorder and its clinical management among adolescents, growing medical applications particularly in older adults for symptom management, and ongoing regulatory fragmentation across jurisdictions that creates inconsistent legal and employment protections. The prevalence of law enforcement actions and failed dispensary permit applications alongside emerging research on cannabis-derived therapeutics suggests the field remains in transition between prohibition and integration into mainstream medicine. Clinically, this landscape underscores the need for evidence-based screening, treatment protocols, and patient counseling on risks and benefits, particularly as cannabinoid products become more potent and accessible while legal status remains variable.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it:
